Table 2.
Intravenous administration simulation parameters.
| Parameter group | Parameter | Value | Source | ||
|
| |||||
| Physicochemical and binding | Mol. weight (g/mol) | 558.6 | [http://www.drugbank.ca/] | ||
| logP | 5.7 | [http://www.drugbank.ca/] | |||
| Compound type | Monoprotic Acid | [http://www.drugbank.ca/] | |||
| pKa 1 | 4.330 | [http://www.drugbank.ca/] | |||
| B/P | 0.610 | [7] | |||
| Fu | 0.107 | [8] | |||
|
| |||||
| ADME | Enzymatic clearance | ||||
| Pathway | p-Hydroxy | o-Hydroxy | p-Hydroxy | ||
| Enzyme | CYP3A4 | CYP3A4 | CYP2C8 | ||
| V max | 29.800 | 29.300 | 0.290 | [9] | |
| K m | 25.600 | 29.700 | 35.900 | ||
| fu mic | 0.662 | 0.662 | 0.662 | ||
| Total plasma clearance-CL (Hep) | 26.93 L/h | [Fitted to the clinical data] | |||
logP—logarithm of the octanol-water partition coefficient; pKa—dissociation constant; B/P—blood-to-plasma partition coefficient; fu—fraction unbound in plasma; V max—maximum reaction rate achieved by the system; K m—substrate concentration at which the reaction rate is half of V max.